| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88095957 | FILING DATE | 08/28/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | PHILLIPS, WENDELL SHAR |
L.O. ASSIGNED | 110 |
PUB INFORMATION |
|||
| RUN DATE | 10/24/2019 | ||
| PUB DATE | 07/02/2019 | ||
| STATUS | 819-SU - REGISTRATION REVIEW COMPLETE | ||
| STATUS DATE | 10/23/2019 | ||
| LITERAL MARK ELEMENT | JORNAY PM | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | JORNAY PM |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Ironshore Pharmaceuticals & Development, Inc. |
| ADDRESS | 10 Market Street, Suite 715 Camana Bay, KY1-9006 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Cayman Islands |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for the treatment of central nervous system diseases and disorders |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 05/00/2019 | FIRST USE IN COMMERCE DATE | 05/00/2019 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| DISCLAIMER W/PREDETER TXT | "PM" |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 10/24/2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 021 |
| 10/23/2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 020 |
| 10/07/2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 019 |
| 09/18/2019 | IUAF | S | USE AMENDMENT FILED | 018 |
| 10/07/2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 017 |
| 09/18/2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 016 |
| 08/27/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 015 |
| 07/02/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 014 |
| 07/02/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 013 |
| 06/12/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 012 |
| 05/23/2019 | ALIE | A | ASSIGNED TO LIE | 011 |
| 05/10/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 010 |
| 05/09/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 05/08/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 05/08/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 12/18/2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 12/18/2018 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 12/18/2018 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 12/11/2018 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 09/07/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 08/31/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Suzanne M. Hengl |
| CORRESPONDENCE ADDRESS | SUZANNE M. HENGL BAKER BOTTS L.L.P. 30 ROCKEFELLER PLAZA 44TH FLOOR NEW YORK, NY 10112-4498 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Ironshore Pharmaceuticals & Development, Inc. |
| ADDRESS | 10 Market Street, Suite 715 Camana Bay, KY1-9006 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Cayman Islands |